Renal transplantation and secondary hyperparathyroidism
โ Scribed by Kazuharu Uchida; Yoshihiro Tominaga; Yuji Tanaka; Hiroshi Takagi
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 140 KB
- Volume
- 13
- Category
- Article
- ISSN
- 8756-0437
No coin nor oath required. For personal study only.
โฆ Synopsis
Secondary hyperparathyroidism (2โฒHPT) improves after renal transplantation (RTx) along with recovered function of the renal allograft. However, normal renal function does not last long due to rejection, drug-induced nephrotoxic nepthropathy, or recurrence of post-transplant glomerulonephritis. Therefore, improved calcium and phosphate metabolism, and parathyroid function after RTx fluctuate in accordance with the function of the renal allograft. In cases with severe 2โฒHPT, parathyroidectomy should be performed before RTx because hypercalcemia due to secondary or tertiary hyperparathyroidism aggravates the renal allograft function. In the follow-up of mild 2โฒHPT after RTx, hypercalcemia and vascular calcification should be monitored carefully by serum parathyroid hormone, calcium and phosphate concentrations, alkaline phosphatase activity, and bone X-ray film. If serum calcium level exceeds 12 mg/dl, parathyroidectomy (PTx) should be performed to prevent the acceleration of vascular calcification. Total PTx with forearm allograft is a preferred surgical procedure for 2โฒHPT even after RTx.
๐ SIMILAR VOLUMES
## Abstract Fifteen patients with histologically proven primary hyperparathyroidism have been investigated with special reference to renal function and the occurrence of hypertension. The patients have been followed up clinically, biochemically, and radiographically for a period of 8 months to 5 ye
Advanced secondary (renal) hyperparathyroidism induced by chronic renal disturbance is one of the most serious complications for long-term hemodialysis patients. Parathyroidectomy is indicated in patients with severely advanced renal hyperparathyroidism refractory to medical treatment (including cal
Control of hyperparathyroidism is a major goal of the management of bone diseases in chronic dialysis patients. Severity of hyperparathyroidism has been evaluated mainly by the level of parathyroid hormone (PTH), however, parathyroid size can be another critical marker. Patients with larger parathyr